153 related articles for article (PubMed ID: 31632581)
21. The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation Over Chemotherapy Alone in the Treatment of Acute Myeloid Leukemia Patients with Mixed Lineage Leukemia (MLL) Rearrangements.
Yang H; Huang S; Zhu CY; Gao L; Zhu HY; Lv N; Jing Y; Yu L
Med Sci Monit; 2016 Jul; 22():2315-23. PubMed ID: 27373985
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-425 upregulation indicates better prognosis in younger acute myeloid leukemia patients undergoing chemotherapy.
Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Hu K; Ke X; Fu L
Oncol Lett; 2019 Jun; 17(6):5793-5802. PubMed ID: 31186806
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
[TBL] [Abstract][Full Text] [Related]
24. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations.
Chou SC; Tang JL; Hou HA; Chou WC; Hu FC; Chen CY; Yao M; Ko BS; Huang SY; Tsay W; Chen YC; Tien HF
Leuk Res; 2014 Nov; 38(11):1278-84. PubMed ID: 25260824
[TBL] [Abstract][Full Text] [Related]
26. BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia.
Zhou JD; Zhang TJ; Xu ZJ; Gu Y; Ma JC; Li XX; Guo H; Wen XM; Zhang W; Yang L; Liu XH; Lin J; Qian J
Diagn Pathol; 2019 Jun; 14(1):68. PubMed ID: 31253168
[TBL] [Abstract][Full Text] [Related]
27. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
[TBL] [Abstract][Full Text] [Related]
28. High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
Zhang H; Zhang N; Wang R; Shao T; Feng Y; Yao Y; Wu Q; Zhu S; Cao J; Zhang H; Li Z; Liu X; Niu M; Xu K
J Transl Med; 2019 Apr; 17(1):106. PubMed ID: 30935386
[TBL] [Abstract][Full Text] [Related]
29. High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia.
Niu M; Feng Y; Zhang N; Shao T; Zhang H; Wang R; Yao Y; Yao R; Wu Q; Cao J; Liu X; Liu Y; Xu K
Cancer Cell Int; 2019; 19():122. PubMed ID: 31080363
[TBL] [Abstract][Full Text] [Related]
30. High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Zhang G; Zhang J; Yang X; Zhang X; Yang S; Wang J; Hu K; Shi J; Ke X; Fu L
Cancer Manag Res; 2019; 11():3053-3060. PubMed ID: 31114350
[No Abstract] [Full Text] [Related]
31. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
32. Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia.
Lee NH; Choi YB; Yi ES; Lee SH; Kim HJ; Lee JW; Sung KW; Koo HH; Yoo KH
Leuk Res; 2016 Nov; 50():57-62. PubMed ID: 27683973
[TBL] [Abstract][Full Text] [Related]
33. High Expression of RhoBTB3 Predicts Favorable Chemothrapy Outcomes in non-M3 Acute Myeloid Leukemia.
Yang SH; Liu W; Peng J; Xu YJ; Liu YF; Li Y; Peng MY; Ou-Yang Z; Chen C; Liu EY
J Cancer; 2021; 12(14):4229-4239. PubMed ID: 34093823
[No Abstract] [Full Text] [Related]
34. Acute myeloid leukemia patient with
Huang Y; Hu J; Lu T; Luo Y; Shi J; Wu W; Han X; Zheng W; He J; Cai Z; Wei G; Huang H; Sun J
Cancer Manag Res; 2019; 11():4129-4142. PubMed ID: 31190985
[No Abstract] [Full Text] [Related]
35. Proteomic identification and structural basis for the interaction between sorting nexin SNX17 and PDLIM family proteins.
Healy MD; Sacharz J; McNally KE; McConville C; Tillu VA; Hall RJ; Chilton M; Cullen PJ; Mobli M; Ghai R; Stroud DA; Collins BM
Structure; 2022 Dec; 30(12):1590-1602.e6. PubMed ID: 36302387
[TBL] [Abstract][Full Text] [Related]
36. [Effect of minimal residual disease monitoring by multiparameter flow cytometry pre-conditioning on prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Lu Y; Wu T; Wang H; Zhao YL; Cao XY; Liu DY; Zhang JP; Xiong M; Zhou JR; Sun RJ; Wei ZJ; Ji SQ; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):118-123. PubMed ID: 28279035
[No Abstract] [Full Text] [Related]
37. Prognostic role of SCAMP family in acute myeloid leukemia.
Qian T; Cheng Z; Quan L; Zeng T; Cui L; Liu Y; Si C; Huang W; Dai Y; Chen J; Liu L; Jiao Y; Deng C; Pang Y; Ye X; Shi J; Fu L
Pharmacogenomics J; 2020 Aug; 20(4):595-600. PubMed ID: 31988488
[TBL] [Abstract][Full Text] [Related]
38. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
[TBL] [Abstract][Full Text] [Related]
39. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
40. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
